Psych Congress Year-Round

Psych Congress Steering Committee members discuss their favorite sessions and aspects of the 31st annual conference, held in Orlando, Fla. Oct. 25-28, 2018.



Sheldon H. Preskorn, MD, has spent 4 decades in the mental health field heavily involved in research. He recently reflected on changes he has seen in psychiatry over his career and where he sees the field and patient treatments headed.

Martha Sajatovic, MD

The world’s population of people aged 60 years and older has doubled since 1980, and, for the first time ever, the number of adults aged 65 years and older is expected to exceed the number of children under 5 by 2020.

Michael Thase, MD

Michael Thase, MD, will review data on emerging medications for depression, outline the pathophysiology of depression, and discuss the limitations of available treatments in a session at the upcoming Psych Congress 2018 conference.

Anticipate some significant changes in the treatment of schizophrenia over the next 10 years, from a move toward coordinated specialty care to harnessing the power of social media to help identify symptoms sooner, said John M. Kane, MD, who will speak on the topic at the upcoming Psych Congress.

Maria Mangini, PhD, FNP-BC

Twenty-nine states and Washington, D.C. currently allow medical cannabis, but concern about the consequences of recommending its use still runs high among practitioners. Maria Mangini, PhD, FNP-BC, will sort out the issue in a presentation at the upcoming Psych Congress.



BLOG: San Francisco is the perfect place to think about the future of psychiatry, and to nurture the generation of new clinicians who will be leading it.

Psych Congress is about building bridges. Like a bridge, we span gaps so that people can come together and learn from one another. There are still bridges to build, and this effort remains a work in progress. We’re only just getting started.

We perpetuate the feeling of being not good enough through slights and microaggressions that we unconsciously inflict upon our peers and colleagues.



Dimitri Grigoriadis, PhD; Evan Smith, JD; Ajay Madan, PhD; Scott Siegert, PharmD; Clinton Wright, PharmD; Haig Bozigian, PhD
Roger McIntyre, MD; Robert Findling, MD; Xiao Wu, PhD; John Edwards, MD; Willie Earley, MD; Chris Gache, MD
Joohi Jimenez-Shahed, MD; Stewart A. Factor, DO; William Ondo, MD; Mat D. Davis, PhD; David Stamler, MD; Robert A. Hauser, MD, MBA; Hubert H. Fernandez, MD
Hubert H. Fernandez, MD; Stewart A. Factor, DO; Joohi Jimenez-Shahed, MD; William Ondo, MD; Mat D. Davis, PhD; David Stamler, MD; Robert A. Hauser, MD, MBA



As the 29th annual Psych Congress kicked off Friday, organizers announced the launch of a new offering, Elevate by Psych Congress, a three-day event designed for early-career clinicians.

Psych Congress featured speaker Jeffrey Swanson, PhD, spoke about the danger of placing blame for the country's scourg

The organizers of Psych Congress debuted new branding for its range of offerings as the its 29th annual national conference got underway Friday.